Navigation Links
Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medical Center
Date:2/20/2013

re the possibilities our technology has enabled."

About Neuralstem

Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem completed dosing of the last patient in an FDA-approved Phase I safety clinical trial for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig 's disease, in August 2012; the trial ends six months after that last surgery. Neuralstem has been awarded orphan status designation by the FDA for its ALS cell therapy.

In addition to ALS, the company is also targeting major central nervous system conditions with its NSI-566 cell therapy platform, including spinal cord injury, ischemic stroke and glioblastoma (brain cancer). The company received approval to commence a Phase I safety trial in chronic spinal cord injury in January 2013.

Neuralstem also has the ability to generate stable human neural stem cell lines suitable for the systematic screening of large chemical libraries. Through this proprietary screening technology, Neuralstem has discovered and patented compounds that may stimulate the brain's capacity to generate new neurons, possibly reversing the pathologies of some central nervous system conditions.  The company is in a Phase Ib safety trial evaluating NSI-189, its first neurogenic small molecule compound, for the treatment of major depressive disorder (MDD). Additional indications could include chronic traumatic encephalopathy (CTE), Alzheimer's disease, and post-traumatic stress disorder (PTSD).

For more information, please visit www.neuralstem.com or connect with us on Twitter,

SOURCE Neuralstem, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neuralstem Updates ALS Stem Cell Trial Progress
2. Sixteenth Patient Dosed In Neuralstem ALS Stem Cell Trial
3. First Patients Dosed in Ib Phase of Neuralstems NSI-189 Trial in Major Depressive Disorder
4. Seventeenth Patient Dosed in Neuralstem ALS Stem Cell Trial
5. Neuralstem Announces Exercise Of Entire Over-Allotment Option By Aegis Capital Corp.
6. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
7. Neuralstem Announces Proposed Public Offering
8. Neuralstem to Raise $7.0 Million in Registered Direct Offering
9. Neuralstem President And CEO To Present At BIO CEO & Investor Conference 2013
10. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
11. Community Foundation Announces $2.6 Million In Grants From Centinela Medical Funds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... WASHINGTON , March 27, 2015 ... - The biopharmaceutical industry comes out on top as ... in a new report  from ndp│analytics. According to ... and development (R&D) investment over the last decade, accounting ... 2000-2012. A Short Video on ...
(Date:3/27/2015)... 27, 2015 A new report from Kalorama Information ... – Chile , Colombia ... targets for IVD firms.  The healthcare research firm said that ... strategies for the Latin American continent with a population of ... supply operations. However, the country,s regional economic clout does not ...
(Date:3/27/2015)... CHINA AID, the ... Rehabilitation Medicine and Healthcare, second to none in ... held at Shanghai New International Expo Center on 22-24 ... Suggestions on Encouraging Private Capital to Participate in the ... issued by the Ministry of Civil Affairs of ...
Breaking Medicine Technology:Week in Review: The Latest from PhRMA 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 4CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 5CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 6
... SEATTLE, Feb. 3, 2011 Dendreon Corporation (Nasdaq: ... its previously announced public offering of 2.875% convertible senior ... closed on its overallotment option in full to purchase ...  The sale of the Notes, including the exercise of ...
... FOREST, Ill., Feb. 3, 2011 Hospira, Inc. (NYSE: ... injectable pharmaceuticals, today announced U.S. Food and Drug Administration ... of the oncology drug approved in the United States. ... had 2010 U.S. sales of more than $140 million. ...
Cached Medicine Technology:Dendreon Announces Exercise and Closing of Overallotment Option 2Hospira Announces FDA Approval of Topotecan Injection 2
(Date:3/28/2015)... MILAN (PRWEB) March 28, 2015 ... thought-leaders in the fields of osteoporosis, osteoarthritis and ... on Osteoporosis, it may be the first time ... educational research forum that the hot-button topic is ... Based on the well-accepted scientific principles of Wolff’s ...
(Date:3/28/2015)... FL (PRWEB) March 28, 2015 ... conditions coverage is made available to all visitors who ... effective immediately. All members are encouraged to purchase the ... to avoid lack of proper coverage for pre-existing medical ... from one or two medical conditions with serious consequences ...
(Date:3/28/2015)... Las Vegas, NV (PRWEB) March 28, 2015 ... surgery experiences re-injury, according to research presented today at ... ) Specialty Day. The study examined the long term ... younger. , “We examined survey data from 242 ... noted lead author Justin P. Roe, MBBS, FRACS, from ...
(Date:3/28/2015)... 2015 Genomic medicine experts have sequenced ... for the first time, key information for understanding and ... the newly posted story on the Surviving Mesothelioma ... British Columbia, the British Columbia Cancer Agency, and PhenoPath ... underlying molecular alterations and mutations that can lead to ...
(Date:3/28/2015)... La Mirada, CA (PRWEB) March 28, 2015 ... with ear, nose and throat disorders, are ... Tinnitus is a common issue which is characterized by ... ears. Affecting 1 in 5 people, tinnitus is a ... or disorder and while it is non-fatal, tinnitus can ...
Breaking Medicine News(10 mins):Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2
... , NEW YORK, Sept. 3 As millions of ... classes every day. , , Teens are at a ... a crash, due largely to lack of experience. Many of those crashes ... (NRSF), a non-profit group that produces free driver education programs. , ...
... PHOENIX, Sept. 3 Maldonado Medical, a Durable ... in continuing its commitment to physicians, patients and the ... (AMA) and other physician associations from several states in ... is against the following health insurers: Aetna Inc., Cigna ...
... Arnhem, September 2009 The September issue of ... Association of Urology, features an article and a video ... Patel et al, showing that the periurethral suspension technique ... after robot-assisted laparoscopic radical prostatectomy (RALP). RALP is ...
... Cancer Institute (NCI) has renewed a $11.5 million Specialized ... and treatment of ovarian cancer, which supports multidisciplinary research ... Pennsylvania. First approved in 1999, this marks the ... "The SPORE program has always been a bold experiment ...
... CLEVELAND, Sept. 3 At a time when many families ... of prescription medications, supermarket retailer Giant Eagle, Inc. is making ... available for free every day at all of its 210 ... Thursday, September 3, with a 10:15 AM kickoff press event ...
... , NEW YORK, Sept. 3 ... its catalogue. , , Anti-aging Products ... http://www.reportlinker.com/p0120340/Anti-aging-Products-and-Services-The-Global-Market.html , , This Report: ... for anti-aging maintenance including health maintenance, beauty and physical fitness , ...
Cached Medicine News:Health News:Back to School Brings Risks to Young Drivers; Traffic Crashes Leading Cause of Teen Death, Says National Road Safety Foundation 2Health News:Maldonado Medical LLC Champions Physician & Patient Rights for Better Reimbursement Schedules Nationwide 2Health News:Maldonado Medical LLC Champions Physician & Patient Rights for Better Reimbursement Schedules Nationwide 3Health News:Maldonado Medical LLC Champions Physician & Patient Rights for Better Reimbursement Schedules Nationwide 4Health News:NCI renews Fox Chase / Penn Ovarian Cancer 'SPORE' grant for a third 5-year term 2Health News:NCI renews Fox Chase / Penn Ovarian Cancer 'SPORE' grant for a third 5-year term 3Health News:NCI renews Fox Chase / Penn Ovarian Cancer 'SPORE' grant for a third 5-year term 4Health News:Giant Eagle Pharmacy to Offer Customers in Ohio a Dose of Economic Relief Through Free Antibiotics Program 2Health News:Giant Eagle Pharmacy to Offer Customers in Ohio a Dose of Economic Relief Through Free Antibiotics Program 3Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 2Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 3Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 4Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 5Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 6Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 7Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 8Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 9Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 10Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 11Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 12Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 13Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 14Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 15Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 16Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 17Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 18Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 19Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 20Health News:Reportlinker Adds Anti-aging Products and Services: The Global Market Report 21
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: